The Therapeutic Goods Administration (TGA) Approved PEMAZYRE (Pemigatinib)
Summary: Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer. The…
Summary: Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer. The…
Synopsis- Zydus announced today that it has received permission to initiate the Phase II (a) clinical study of its NLRP3 inhibitor “ZYIL1”…
Synopsis: The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…
This information is provided to assist you if you are new to engaging with the TGA and Australia’s regulatory framework for medical…